Establishment and validation of a prognostic model based on common laboratory indicators for SARS-CoV-2 infection in Chinese population
Authors:
Open Access
- 6 September 2024
- journal article
- research article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 56 (1) , 2400312
Abstract
At the beginning of December 2022, the Chinese government made major adjustments to the epidemic prevention and control measures. The epidemic infection data and laboratory makers for infected patients based on this period may help with the management and prognostication of COVID-19 patients. The COVID-19 patients hospitalized during December 2022 were enrolled. Logistic regression analysis was used to screen significant factors associated with mortality in patients with COVID-19. Candidate variables were screened by LASSO and stepwise logistic regression methods and were used to construct logistic regression as the prognostic model. The performance of the models was evaluated by discrimination, calibration, and net benefit. 888 patients were eligible, consisting of 715 survivors and 173 all-cause deaths. Factors significantly associated with mortality in COVID-19 patients were: lactate dehydrogenase (LDH), albumin (ALB), procalcitonin (PCT), age, smoking history, malignancy history, high density lipoprotein cholesterol (HDL-C), lactate, vaccine status and urea. 335 of the 888 eligible patients were defined as ICU cases. Seven predictors, including neutrophil to lymphocyte ratio, D-dimer, PCT, C-reactive protein, ALB, bicarbonate, and LDH, were finally selected to establish the prognostic model and generate a nomogram. The area under the curve of the receiver operating curve in the training and validation cohorts were respectively 0.842 and 0.853. In terms of calibration, predicted probabilities and observed proportions displayed high agreements. Decision curve analysis showed high clinical net benefit in the risk threshold of 0.10-0.85. A cutoff value of 81.220 was determined to predict the outcome of COVID-19 patients via this nomogram. The laboratory model established in this study showed high discrimination, calibration, and net benefit. It may be used for early identification of severe patients with COVID-19.Keywords
Funding Information
- Sichuan Province Science and Technology Program (2022NSFSC1283)
This publication has 44 references indexed in Scilit:
- Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19JAMA Network Open, 2023
- Biochemistry tests in hospitalized COVID-19 patients: Experience from a Canadian tertiary care centreClinical Biochemistry, 2021
- Development and validation of a nomogram using on admission routine laboratory parameters to predict in‐hospital survival of patients with COVID‐19Journal of Medical Virology, 2020
- Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infectionClinica Chimica Acta, 2020
- Predictive modeling of blood pressure during hemodialysis: a comparison of linear model, random forest, support vector regression, XGBoost, LASSO regression and ensemble methodComputer Methods and Programs in Biomedicine, 2020
- Clinical laboratory characteristics in patients with suspected COVID‐19: One single‐institution experienceJournal of Medical Virology, 2020
- Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19JAMA Internal Medicine, 2020
- Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and MortalityJAMA Cardiology, 2020
- Differences between COVID‐19 and suspected then confirmed SARS‐CoV‐2‐negative pneumonia: A retrospective study from a single centerJournal of Medical Virology, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020